Table 2.
2C3–Ig sequence analysis by prediction software (syfpeithi and bimas programs) to identify cytotoxic T-lymphocyte (CTL) epitopes from associated complementarity-determining regions (CDRs) and framework regions (FRs)
| MHC binding score | |||||||
|---|---|---|---|---|---|---|---|
| syfpeithi22 | bimas23 | ||||||
| Origin | Position | Sequence | Kd | Ld | Kd | Dd | Ld |
| IgH | CDR3 | YYGSSYGFA | 20 | 13 | 72 | 2 | 13 |
| IgH | FR1 + CDR1 | GFTFSDYYI | 18 | 9 | 960 | 2·88 | 10 |
| IgH | FR1 | RLVESGGGL | 17 | 11 | 115·2 | 1·2 | 5 |
| IgH | FR1 | GLVKPGGSL | 16 | 5 | 80 | 1 | 5 |
| IgH | CDR1 | IYWVRQTPE | 16 | 3 | 100 | <1 | <1 |
| IgH | CDR3 | GYYGSSYGF | 13 | 12 | 60 | <1 | 10 |
| IgH | CDR2 | SDGGSYTYY | 12 | 3 | <1 | <1 | <1 |
| IgH | CDR1 | TFSDYYIYW | 10 | 8 | 24 | <1 | <1 |
| IgKappa | FR1 | TPLSLPVSL | 20 | 21 | 115·2 | <1 | 150 |
| IgKappa | CDR3 | YFCSQSTHV | 19 | <1 | 288·0 | <1 | <1 |
| IgKappa | CDR3 + FR4 | WTFGGGTKL | 18 | 13 | 57·6 | <1 | 6·5 |
| IgKappa | FR1 | VSLGDQASI | 17 | 14 | 96 | <1 | <1 |
| IgKappa | FR1 | SCRSSQSLV | 17 | <1 | 57·6 | <1 | <1 |
| IgKappa | FR3 | SGSGTDFTL | 16 | 12 | 48 | 12 | <1 |
| IgKappa | FR1 | ISCRSSQSL | 15 | 20 | 48 | <1 | 25 |
| IgKappa | CDR1 | VHSNGNTYL | 15 | 15 | <1 | <1 | 10 |
| IgKappa | CDR2 | IYKVSNRFS | 15 | <1 | 60 | <1 | 10 |
| IgKappa | CDR3 + FR4 | TFGGGTKLE | 13 | 3 | <1 | <1 | 6·5 |
MHC, major histocompatibility complex.